Journal rankings · indicator year 2010
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2010
Infectious Diseases journal rankings 2010
118 ranked journals · Subfield in Medicine
Infectious Diseases has 118 ranked journals in 2010. Its median journal scores above the world average: OJR 1.01 against 1.00, up 0.01 on 2009. A journal needs OJR 1.65 to reach Q1. The top three are New England Journal of Medicine, Clinical Microbiology Reviews, and PLoS Medicine.
Ranks and citation indicators: 2010. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2007–2009, the window the 2010 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery531
- Pulmonary and Respiratory Medicine221
- Cardiology and Cardiovascular Medicine190
- Public Health, Environmental and Occupational Health184
- Oncology141
- Epidemiology129
- Infectious Diseases118
- Radiology, Nuclear Medicine and Imaging105
- Psychiatry and Mental health102
- Endocrinology, Diabetes and Metabolism101
- Neurology95
- Physiology95
Show all 42 subfields
- Orthopedics and Sports Medicine72
- Pediatrics, Perinatology and Child Health65
- Ophthalmology60
- Hematology57
- Dermatology56
- Obstetrics and Gynecology43
- Rheumatology43
- Nephrology37
- Reproductive Medicine36
- Pharmacology35
- Complementary and alternative medicine34
- Emergency Medicine31
- Geriatrics and Gerontology26
- Otorhinolaryngology25
- Pathology and Forensic Medicine21
- Rehabilitation18
- Critical Care and Intensive Care Medicine15
- Immunology and Allergy14
- Genetics11
- Hepatology10
- Urology10
- Anesthesiology and Pain Medicine8
- Gastroenterology7
- Internal Medicine4
- Family Practice2
- Transplantation2
- Biochemistry1
- Anatomy0
- Health Informatics0
- Microbiology0
118 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2009. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2007–2009, the window the 2010 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2007–2009 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2001 to 2010. | Compare |
|---|---|---|---|---|---|---|---|
1New England Journal of MedicineMassachusetts Medical Society · United States | 13.37Q1 | 27.46 3.51 up from 2009 | 2,831 | 36% | — | ||
2Clinical Microbiology ReviewsAmerican Society for Microbiology · United States | 10.82Q1 | 18.53 0.92 down from 2009 | 104 | 94% | — | ||
3PLoS MedicineOAPublic Library of Science · United States | 4.90Q1 | 11.52 1.40 up from 2009 | 742 | 100% | $6,460 | ||
4PLoS PathogensOAPublic Library of Science · United States | 4.54Q1 | 10.46 0.02 up from 2009 | 940 | 100% | $3,043 | ||
5The Lancet Infectious DiseasesElsevier BV · Netherlands | 3.97Q1 | 9.80 0.42 up from 2009 | 346 | 20% | $7,280 | ||
6Annals of Internal MedicineAmerican College of Physicians · United States | 3.90Q1 | 8.25 0.50 down from 2009 | 1,250 | 8% | — | ||
7Clinical Infectious DiseasesOxford University Press · United States | 3.37Q1 | 7.50 0.40 up from 2009 | 2,283 | 40% | $4,763 | ||
8The Journal of Infectious DiseasesOxford University Press · United States | 2.82Q1 | 6.80 0.54 up from 2009 | 1,760 | 60% | $4,763 | ||
9Reviews in Medical VirologyWiley · United Kingdom | 2.73Q1 | 5.72 0.67 down from 2009 | 90 | 22% | $4,880 | ||
10Emerging infectious diseasesOACenters for Disease Control and Prevention · United States | 2.71Q1 | 5.36 0.09 down from 2009 | 1,748 | 100% | — | ||
11AIDSLippincott Williams & Wilkins · United Kingdom | 2.29Q1 | 6.23 1.06 up from 2009 | 1,444 | 36% | — | ||
12EurosurveillanceOAEuropean Centre for Disease Prevention and Control · Sweden | 2.13Q1 | 5.26 2.90 up from 2009 | 657 | 100% | — | ||
13Journal of Clinical MicrobiologyOAAmerican Society for Microbiology · United States | 2.08Q1 | 4.77 0.07 up from 2009 | 2,342 | 100% | — | ||
14Antimicrobial Agents and ChemotherapyOAAmerican Society for Microbiology · United States | 2.05Q1 | 5.13 0.17 down from 2009 | 2,384 | 99% | — | ||
15Interdisciplinary Perspectives on Infectious DiseasesOAHindawi Publishing Corporation · United Kingdom | 2.04Q1 | 3.98 2.69 up from 2009 | 42 | 100% | $860 | ||
16JAIDS Journal of Acquired Immune Deficiency SyndromesLippincott Williams & Wilkins · United States | 2.04Q1 | 4.82 0.30 up from 2009 | 978 | 48% | — | ||
17Journal of Antimicrobial ChemotherapyOxford University Press · United Kingdom | 1.91Q1 | 4.76 0.05 up from 2009 | 1,538 | 40% | $3,784 | ||
18Antiviral ResearchElsevier BV · Netherlands | 1.86Q1 | 4.71 0.76 up from 2009 | 407 | 16% | $4,160 | ||
19Clinical Microbiology and InfectionElsevier BV · United Kingdom | 1.83Q1 | 3.68 0.66 down from 2009 | 1,031 | 91% | $3,780 | ||
20Tropical Medicine & International HealthWiley · United Kingdom | 1.80Q1 | 3.38 0.39 up from 2009 | 595 | 59% | $3,400 | ||
21American Journal of Infection ControlElsevier BV · United States | 1.76Q1 | 3.23 0.31 down from 2009 | 524 | 16% | $3,360 | ||
22Current HIV/AIDS ReportsSpringer Science+Business Media · United States | 1.73Q1 | 4.05 0.56 up from 2009 | 85 | 55% | $4,190 | ||
23International Journal of Medical MicrobiologyOAElsevier BV · Germany | 1.73Q1 | 2.76 0.27 down from 2009 | 270 | 9% | $3,410 | ||
24BMC Infectious DiseasesOABioMed Central · United Kingdom | 1.72Q1 | 3.80 0.29 up from 2009 | 537 | 100% | $3,090 | ||
25AIDS and BehaviorSpringer Science+Business Media · Netherlands | 1.69Q1 | 3.45 0.61 up from 2009 | 451 | 67% | $4,590 | ||
26Microbes and InfectionElsevier BV · France | 1.67Q1 | 3.45 0.30 up from 2009 | 556 | 100% | $3,510 | ||
27Infection Genetics and EvolutionOAElsevier BV · Netherlands | 1.67Q1 | 3.70 0.64 up from 2009 | 376 | 22% | $2,730 | ||
28AIDS Education and PreventionGuilford Press · United States | 1.66Q1 | 2.39 0.02 up from 2009 | 151 | 49% | — | ||
29Journal of InfectionOAElsevier BV · United Kingdom | 1.65Q1 | 3.65 0.63 up from 2009 | 505 | 14% | $4,030 | ||
30Journal of General VirologyMicrobiology Society · United Kingdom | 1.65Q1 | 3.66 0.26 down from 2009 | 1,211 | 37% | — | ||
31HIV MedicineWiley · United Kingdom | 1.64Q2 | 4.16 0.17 up from 2009 | 317 | 60% | $4,150 | ||
32Infection Control and Hospital EpidemiologyCambridge University Press · United Kingdom | 1.63Q2 | 2.35 0.23 up from 2009 | 1,375 | 22% | $3,550 | ||
33Antiviral TherapyOASAGE Publishing · United Kingdom | 1.62Q2 | 3.83 0.18 down from 2009 | 435 | 41% | $2,800 | ||
34AnaerobeElsevier BV · United Kingdom | 1.62Q2 | 2.78 0.66 up from 2009 | 182 | 5% | $3,350 | ||
35Medical Microbiology and ImmunologySpringer Science+Business Media · Germany | 1.54Q2 | 3.46 0.69 down from 2009 | 104 | 15% | $5,090 | ||
36Expert Review of Anti-infective TherapyTaylor & Francis · United Kingdom | 1.53Q2 | 3.25 0.06 down from 2009 | 288 | 41% | — | ||
37Future MicrobiologyFuture Medicine · United Kingdom | 1.52Q2 | 3.14 0.27 up from 2009 | 249 | 25% | — | ||
38British Journal of Clinical PharmacologyWiley · United Kingdom | 1.51Q2 | 3.00 0.02 down from 2009 | 724 | 92% | $4,780 | ||
39Virus ResearchOAElsevier BV · Netherlands | 1.44Q2 | 3.13no change | 727 | 25% | $3,010 | ||
40AIDS CareTaylor & Francis · United Kingdom | 1.41Q2 | 2.47 0.05 down from 2009 | 529 | 34% | — | ||
41Epidemiology and InfectionOACambridge University Press · United Kingdom | 1.39Q2 | 2.52 0.23 down from 2009 | 622 | 100% | $3,550 | ||
42Virology JournalOABioMed Central · United Kingdom | 1.38Q2 | 3.24 0.24 up from 2009 | 527 | 100% | $3,290 | ||
43AIDS Patient Care and STDsMary Ann Liebert, Inc. · United States | 1.37Q2 | 3.18 0.30 down from 2009 | 343 | 48% | — | ||
44Journal of Medical MicrobiologyMicrobiology Society · United Kingdom | 1.36Q2 | 2.81 0.28 up from 2009 | 905 | 17% | — | ||
45FEMS Immunology & Medical MicrobiologyOxford University Press · Netherlands | 1.36Q2 | 2.86 0.01 down from 2009 | 461 | 69% | — | ||
46Diagnostic Microbiology and Infectious DiseaseElsevier BV · United States | 1.35Q2 | 2.95 0.19 down from 2009 | 717 | 11% | $3,290 | ||
47Infectious Disorders - Drug TargetsBentham Science Publishers · Netherlands | 1.29Q2 | 2.77 0.24 down from 2009 | 98 | 7% | — | ||
48Journal of Medical VirologyWiley · United States | 1.28Q2 | 3.37 0.28 up from 2009 | 864 | 26% | $4,730 | ||
49InfectionSpringer Science+Business Media · Germany | 1.23Q2 | 2.84 0.85 up from 2009 | 327 | 38% | $4,790 | ||
50Journal of Hospital InfectionElsevier BV · United Kingdom | 1.20Q2 | 2.68 0.39 down from 2009 | 737 | 7% | $4,000 |
Subfields of Medicine, with Infectious Diseases highlighted.
- Surgery531
- Pulmonary and Respiratory Medicine221
- Cardiology and Cardiovascular Medicine190
- Public Health, Environmental and Occupational Health184
- Oncology141
- Epidemiology129
- Infectious Diseases118
- Radiology, Nuclear Medicine and Imaging105
- Psychiatry and Mental health102
- Endocrinology, Diabetes and Metabolism101
- Neurology95
- Physiology95
- Orthopedics and Sports Medicine72
- Pediatrics, Perinatology and Child Health65
- Ophthalmology60
- Hematology57
- Dermatology56
- Obstetrics and Gynecology43
- Rheumatology43
- Nephrology37
- Reproductive Medicine36
- Pharmacology35
- Complementary and alternative medicine34
- Emergency Medicine31
- Geriatrics and Gerontology26
- Otorhinolaryngology25
- Pathology and Forensic Medicine21
- Rehabilitation18
- Critical Care and Intensive Care Medicine15
- Immunology and Allergy14
- Genetics11
- Hepatology10
- Urology10
- Anesthesiology and Pain Medicine8
- Gastroenterology7
- Internal Medicine4
- Family Practice2
- Transplantation2
- Biochemistry1
- Anatomy0
- Health Informatics0
- Microbiology0
Journals
Citations made in 2010. Corpus-wide, 73.2% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
48 additional Infectious Diseases journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2007–2009, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2010. Publication window: 2007–2009. How these summaries are calculated
- Ranked journals
- 118
- Window papers (baseline)
- 46,364 +32.2% from indicator year 2007
- Median OJR
- 1.01 +8.7% from indicator year 2007
- Rising journals (2025)
- 48
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2007–2009 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 70 | 73 | 78 | 82 | 86 | 92 | 95 | 101 | 106 | 110 | 118 | 131 | 144 | 162 | 173 | 182 | 189 | 198 | 210 | 217 | 222 | 234 | 243 | 259 | 263 | 258 | |
| Window papers (baseline) | 18,375 | 21,167 | 22,805 | 24,640 | 25,208 | 28,008 | 31,333 | 35,063 | 38,170 | 42,272 | 46,364 | 49,515 | 52,080 | 54,445 | 58,513 | 62,728 | 67,259 | 69,548 | 70,742 | 70,658 | 72,743 | 100,768 | 135,954 | 162,915 | 153,103 | 130,899 | |
| Median OJR | 0.602 | 0.68 | 0.82 | 0.76 | 0.77 | 0.901 | 0.98 | 0.93 | 1.04 | 0.998 | 1.01 | 0.999 | 0.97 | 0.900 | 0.91 | 0.874 | 0.85 | 0.8699 | 0.8696 | 0.83 | 0.80 | 0.597 | 0.61 | 0.64 | 0.70 | 0.75 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.